These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 24000886

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen.
    Kotlín R, Reicheltová Z, Malý M, Suttnar J, Sobotková A, Salaj P, Hirmerová J, Riedel T, Dyr JE.
    Thromb Haemost; 2009 Sep; 102(3):479-86. PubMed ID: 19718467
    [Abstract] [Full Text] [Related]

  • 4. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.
    Haverkate F, Samama M.
    Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysis.
    Westbury SK, Duval C, Philippou H, Brown R, Lee KR, Murden SL, Phillips E, Reilly-Stitt C, Whalley D, Ariëns RA, Mumford AD.
    Thromb Haemost; 2013 Dec; 110(6):1135-44. PubMed ID: 24048413
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia.
    Koopman J, Haverkate F, Grimbergen J, Lord ST, Mosesson MW, DiOrio JP, Siebenlist KS, Legrand C, Soria J, Soria C.
    J Clin Invest; 1993 Apr; 91(4):1637-43. PubMed ID: 8473507
    [Abstract] [Full Text] [Related]

  • 10. Familial thrombophilia associated with fibrinogen paris V: Dusart syndrome.
    Tarumi T, Martincic D, Thomas A, Janco R, Hudson M, Baxter P, Gailani D.
    Blood; 2000 Aug 01; 96(3):1191-3. PubMed ID: 10910944
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
    Grailhe P, Boyer-Neumann C, Haverkate F, Grimbergen J, Larrieu MJ, Anglés-Cano E.
    Blood Coagul Fibrinolysis; 1993 Oct 01; 4(5):679-87. PubMed ID: 8292717
    [Abstract] [Full Text] [Related]

  • 16. Two novel mutations in the fibrinogen γ nodule.
    Kotlín R, Pastva O, Stikarová J, Hlaváčková A, Suttnar J, Chrastinová L, Riedel T, Salaj P, Dyr JE.
    Thromb Res; 2014 Oct 01; 134(4):901-8. PubMed ID: 25074738
    [Abstract] [Full Text] [Related]

  • 17. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F, Koopman J, Kluft C, D'Angelo A, Cattaneo M, Mannucci PM.
    Thromb Haemost; 1986 Feb 28; 55(1):131-5. PubMed ID: 3705000
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function.
    Undas A, Zdziarska J, Iwaniec T, Stepien E, Skotnicki AB, de Moerloose P, Neerman-Arbez M.
    Thromb Haemost; 2009 May 28; 101(5):975-6. PubMed ID: 19404553
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.